β blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial (vol 393, pg 1597, 2019)

被引：0
|
作者：
Villanueva, C.
Albillos, A.
Genesca, J.
机构：
来源：
LANCET | 2019年 / 393卷 / 10190期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2492 / 2492
页数：1
相关论文
共 50 条
  • [41] HOMOCYSTEINE AND MENTAL HEALTH IN OLDER PATIENTS: A RANDOMISED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL
    Gariballa, S. E.
    AGE AND AGEING, 2011, 40 : II11 - II11
  • [42] Riluzole in patients with hereditary cerebellar ataxia: a randomised, double-blind, placebo-controlled trial
    Romano, Silvia
    Coarelli, Giulia
    Marcotulli, Christian
    Leonardi, Luca
    Piccolo, Francesca
    Spadaro, Maria
    Frontali, Marina
    Ferraldeschi, Michela
    Vulpiani, Maria Chiara
    Ponzelli, Federica
    Salvetti, Marco
    Orzi, Francesco
    Petrucci, Antonio
    Vanacore, Nicola
    Casali, Carlo
    Ristori, Giovanni
    LANCET NEUROLOGY, 2015, 14 (10): : 985 - 991
  • [43] Regular, sustained-release morphine for chronic breathlessness: a multicentre, double-blind, randomised, placebo-controlled trial (vol 75, pg 50, 2020)
    Currow, D.
    Louw, S.
    McCloud, P.
    THORAX, 2020, 75 (07) : E5 - E5
  • [44] A randomized, double-blind, placebo-controlled trial of rifaximin to prevent travelers' diarrhea (vol 142, pg 805, 2005)
    DuPont, HL
    Jiang, ZD
    Okhuysen, PC
    Ericsson, CD
    de la Cabada, FJ
    Ke, S
    ANNALS OF INTERNAL MEDICINE, 2005, 143 (03) : 239 - 239
  • [45] MEMO: an mHealth intervention to prevent the onset of depression in adolescents: a double-blind, randomised, placebo-controlled trial
    Whittaker, Robyn
    Stasiak, Karolina
    McDowell, Heather
    Doherty, Iain
    Shepherd, Matthew
    Chua, Shireen
    Dorey, Enid
    Parag, Varsha
    Ameratunga, Shanthi
    Rodgers, Anthony
    Merry, Sally
    JOURNAL OF CHILD PSYCHOLOGY AND PSYCHIATRY, 2017, 58 (09) : 1014 - 1022
  • [46] A MULTICENTRE RANDOMISED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL OF ZOLEDRONIC ACID FOR KNEE OSTEOARTHRITIS - THE ZAP2 TRIAL
    Aitken, D.
    Cai, G.
    Laslett, L. L.
    Hill, C.
    March, L.
    Cicuttini, F.
    Wluka, A. E.
    Wang, Y.
    Antony, B.
    Blizzard, L.
    Winzenberg, T.
    Martel-Pelletier, J.
    Pelletier, J. -P.
    Jones, G.
    OSTEOARTHRITIS AND CARTILAGE, 2020, 28 : S79 - S80
  • [47] A randomised, multicentre, double-blind, placebo-controlled trial of etanercept in adults with refractory heel enthesitis in spondyloarthritis: the HEEL trial
    Dougados, Maxime
    Combe, Bernard
    Braun, Juergen
    Landewe, Robert
    Sibilia, Jean
    Cantagrel, Alain
    Feydy, Antoine
    van der Heijde, Desiree
    Leblanc, Veronique
    Logeart, Isabelle
    ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 (08) : 1430 - 1435
  • [48] A prospective, multicentre, randomised, double-blind, placebo-controlled trial to evaluate the efficacy of PFO closure with the STARFlex® device to prevent refractory migraine:: The MIST trial
    Dowson, A. J.
    Wilmshurst, P.
    Muir, K. W.
    Mullen, M.
    Nightingale, S.
    EUROPEAN JOURNAL OF NEUROLOGY, 2006, 13 : 22 - 22
  • [49] A randomised, placebo-controlled, double-blind, crossover study of losartan and enalapril in patients with essential hypertension
    Fagard, R
    Lijnen, P
    Pardaens, K
    Thijs, L
    Vinck, W
    JOURNAL OF HUMAN HYPERTENSION, 2001, 15 (03) : 161 - 167
  • [50] A randomised, placebo-controlled, double-blind, crossover study of losartan and enalapril in patients with essential hypertension
    R Fagard
    P Lijnen
    K Pardaens
    L Thijs
    W Vinck
    Journal of Human Hypertension, 2001, 15 : 161 - 167
12345